Review

Prognostic Value of Cardiac-Specific Troponins in Intracranial Hemorrhage

Authors: Ashraf S. Abdo, MD, Stephen A. Geraci, MD

Abstract

Background: Cardiac-specific troponin (Tn) serum concentrations have proved to be important diagnostic and prognostic markers for acute myocardial infarction. Elevated levels in the setting of noncardiac diseases such as intracerebral hemorrhage also may provide useful prognostic information regarding outcome.


Methods: A systematic review of the English-language medical literature was performed using PubMed. Articles reporting original data were included.


Results: Ten reports qualified for review. A spectrum of cardiac abnormalities was observed in studied patients, sometimes more frequently in those with Tn elevations, whereas some had no such abnormalities, even if Tn was detected. Although some studies suggested a worse outcome in patients with elevated Tn levels, the findings were inconsistent.


Conclusions: At this time, although the literature suggests an association between cardiac-specific Tn elevations and clinical events in patients with intracranial hemorrhage, data are insufficient to conclude that there is a consistent predictive value or to recommend routine Tn monitoring for prognosis.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin 1992; 10: 167–176.
 
2. Mehta NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95: 13–17.
 
3. Baillard C, Boussarsar M, Fosse JP, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003; 29: 584–589.
 
4. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088–3096.
 
5. Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004; 22: 3751–3757.
 
6. Velmahos GC, Karaiskakis M, Salim A, et al. Normal electrocardiography and serum tropon in I levels preclude the presence of clinically significant blunt cardiac injury. J Trauma 2003; 54: 45–51.
 
7. Garrett MC, Komotar RJ, Starke RM, et al. Elevated troponin levels are predictive of mortality in surgical intracerebral hemorrhage patients. Neurocrit Care 2010; 12: 199–203.
 
8. Turck N, Vutskits L, Sanchez-Pena P, et al. A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med 2010; 36: 107–115.
 
9. Hravnak M, Frangiskakis JM, Crago EA, et al. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke 2009; 40: 3478–3484.
 
10. Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 2008; 102: 632–634.
 
11. Tanabe M, Crago EA, Suffoletto MS, et al. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol 2008; 102: 1545–1550.
 
12. Hasegawa K, Fix ML, Wendell L, et al. Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage. Am J Emerg Med 2011 Mar 28. [Epub ahead of print]
 
13. Maramattom BV, Manno EM, Fulgham JR, et al. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc 2006; 81: 192–196.
 
14. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005; 112: 2851–2856.
 
15. Chalela JA, Ezzeddine MA, Davis L, et al. Myocardial injury in acute stroke: a troponin I study. Neurocrit Care 2004; 1: 343–346.
 
16. Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006; 66: 1330–1334.
 
17. van der Bilt IA, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009; 72: 635–642.
 
18. Naredi S, Lambert G, Edén E, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000; 31: 901–906.
 
19. Lobato RD, Marín J, Salaices M, et al. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage. J Neurosurg 1980; 53: 480–485.
 
20. Sandvei MS, Amundsen BH, Haugen BO, et al. Left ventricular myocardial function during the acute phase of a subarachnoid haemorrhage. Scand Cardiovasc J 2009; 43: 110–116.
 
21. Dorfman TA, Iskandrian AE. Takotsubo cardiomyopathy: state-of-the-art review. J Nucl Cardiol 2009; 16: 122–134.
 
22. Richard C. Stress-related cardiomyopathies. Ann Intensive Care 2011; 1: 39.
 
23. Geraci SA. Canary in the coal mine: cardiac troponins in non-coronary diseases. Am J Med 2012 Feb 9. [Epub ahead of print]